Artemis Medicare Services Ltd. Share Price Target from 2025 to 2050: Future Outlook
Artemis Medicare Services Ltd., part of the Apollo Tyres Group, has built a reputation as a high-quality healthcare operator in India with its flagship Artemis Hospital in Gurugram and a network of Artemis Lite outpatient models. With strong accreditations, expanding capacity, and an increasing footprint, Artemis is positioning itself as a formidable name in tertiary and neighborhoods healthcare delivery. In this post, we explore its share price target & forecast from 2025 to 2050, covering its core operations, investment appeal, and key future growth drivers.
Artemis Medicare Services Ltd. Overview: Growth, Products, & Market Presence
Artemis Medicare Services operates a 541-bed multi-specialty tertiary care hospital in Gurugram, offering specialties including orthopaedics, oncology, cardiovascular, neurology, and minimally invasive surgery. Accredited by NABH and JCI multiple times, the company has expanded into segments like mother-and-child care (Daffodils by Artemis), small-format community hospitals (Artemis Lite), cardiac centres, and wellness units. With a dominant presence in Delhi–NCR and aspirations to scale, Artemis is building a layered healthcare delivery model.
| Details | Information |
|---|---|
| Founded | 2004 (by Apollo Tyres Group promoters) |
| Sector | Healthcare & Hospital Services |
| Key Services | Multi‑specialty hospital, Daffodils mother‑child care, Artemis Lite, cardiac centres |
| Stock Listings | NSE: ARTEMISMED; BSE: 542919 |
| Market Presence | Gurugram flagship plus neighbourhood hospitals in Delhi NCR |
On this page, you will find detailed insights into Artemis Medicare Services Ltd.’s stock, including real-time prices, technical analysis, and long-term forecasts:
✅ Real-Time Stock Price: Updated every minute with the latest market data.
✅ Technical Indicators: Tailored by time frame for accurate trading insights.
✅ Financial Reports: Published quarterly to reflect the company’s performance.
✅ Stock Charts: Refreshed in real time for visual market analysis.
📊 Note: Artemis Medicare Services Ltd.’s stock forecast prices in the tables are automatically updated based on live asset price changes.
Artemis Medicare Services Ltd. Financial Overview & Key Metrics
Artemis has demonstrated steady revenue and margin growth powered by capacity expansion and rising operational efficiency. Management has reinvested in infrastructure—including Tower III at the flagship and multiple Lite clinics—to diversify service offerings. This growth trajectory supports Artemis’s positioning as a high-quality, premium care provider with increasing patient inflow and improved unit economics.
Below is a detailed breakdown of its key financial figures, including revenue, net profit, earnings per share (EPS), and other crucial metrics. These insights enable investors to assess the company’s financial health and long-term growth potential.
Use the landscape mode for best viewing on mobile devices.
Investment Potential & Associated Risks
Why Consider Investing in Artemis Medicare Services Ltd.?
- Clinical Excellence with Premium Accreditation
Artemis holds both NABH and JCI accreditations and leads in advanced procedures like CyberKnife and robotic surgeries, showcasing its clinical benchmark status. - Multi-format Healthcare Model
With both a world-class tertiary hospital and smaller Artemis Lite centres, Artemis delivers both high-end care and convenient neighbourhood services, tapping diverse patient profiles. - Strategic Capacity Expansion
The addition of Tower III in the Gurugram facility is set to add around 150 more beds, enhancing scale and expected to be operational by early FY 2025. - Battery of Care Delivery Channels
Revenue streams include inpatient tertiary care, outpatient clinics, Daffodils maternity services, diagnostics, and managed care, offering a balanced mix of volume and value. - Opportunity in Medical Tourism
Strong clinical reputation combined with advanced facilities makes Artemis well-positioned to attract international patients for procedures, supporting higher billing potential.
Risks to Consider
- High Capital Intensity and Utilisation Risk
New infrastructure requires significant capital outlay. If utilization lags post-expansion, near-term returns may be muted. - Cutthroat Regional Competition
In Delhi–NCR, Artemis competes with established players like Medanta and Max. Sustaining market share requires consistent service excellence and price competitiveness. - Regulatory & Cost Compliance Pressures
Maintaining top-tier accreditation and upgrading technology are expensive essentials, requiring ongoing investment in staff, equipment, and systems. - Geographic Revenue Concentration
Most operations remain localized to one flagship hospital. While international patients contribute significantly, core business still relies on a single region. - Patient Experience and Brand Perception Variance
While generally well-regarded, mixed patient reviews around billing, turnaround time, and service personalization may affect perception over time.
Artemis Medicare Services Share Price Target: Tomorrow & Weekly Outlook
Artemis Medicare Services stock price forecasts for tomorrow and the upcoming week are based on recent market trends, historical price movements, and key technical indicators. These projections provide valuable insights into potential price changes, enabling traders and investors to make informed decisions.
However, various factors can influence stock prices, including market sentiment, news updates, and global events; therefore, it’s always wise to stay updated and flexible with your strategies.
📊 Below, you will find the expected stock price targets for the coming days:
| Date | Min. Price | Max. Price | Stock Price |
|---|---|---|---|
| 08-Aug | 241.22 | 254.83 | 247.86 |
| 11-Aug | 240.23 | 254.61 | 247.48 |
| 12-Aug | 239.14 | 253.18 | 245.90 |
| 13-Aug | 238.49 | 253.04 | 246.05 |
| 14-Aug | 237.16 | 251.12 | 244.10 |
| 15-Aug | 238.44 | 251.98 | 245.46 |
| 18-Aug | 237.52 | 251.45 | 245.08 |
| 19-Aug | 236.54 | 250.29 | 243.50 |
| 20-Aug | 236.63 | 250.84 | 243.65 |
Technical Analysis of Artemis Medicare Services Ltd. Using Key Indicators
For Artemis Medicare Services Ltd., you can leverage indicator-based technical analysis to identify optimal market entry and exit points. Adjust the time frame according to your trading strategy for more accurate insights.
How to Interpret Technical Analysis Signals:
| ✅ Sell” or “Strong Sell | Indicates bearish (negative) market sentiment, suggesting a potential decline. |
| ✅ Buy” or “Strong Buy | Indicates bullish (positive) market sentiment, signaling a potential uptrend. |
Time Frame Considerations:
- Short-Term Analysis (Intraday/Short Swing Trading): Use time frames ranging from 15 minutes to 2 hours.
- Medium to Long-Term Analysis: If you plan to hold for more than a week, use daily to weekly time frames.
Below, you will find technical indicator-based buy and sell signals based on different time frames to assist in your investment decisions.
Future Growth Drivers for Artemis Medicare Services Ltd.
- Gurugram Tower III & Beyond
Expanding capacity and enhancing specialty care offerings will boost bed utilization and average revenue per occupied bed. - Scaling Artemis Lite & Daffodils Formats
Growth of convenient care models and mother-child services extends reach beyond high-infrastructure facilities into the neighbourhood healthcare ecosystem. - Technology & Service Differentiation
Investment in robotics, CyberKnife, and telemedicine provides a clinical edge and attracts complex case loads, supporting premium pricing. - Medical Tourism & Partnerships
Alliances with insurers, international health providers, and medical tourism platforms can drive higher foreign-patient inflow. - Rising Insurance Penetration & Preventive Care Uptake
As insurance coverage increases, Artemis can leverage wellness packages, corporate tie-ups, and preventive care services to drive recurring volume.
What Will Drive Artemis Medicare Services’ Share Price Over the Coming Decades?
- Improved utilisation and higher ARPOB via capacity and service enhancements
- Expansion into suburban and Tier‑2 areas through Lite-style clinics
- Uptick in margin and margin visibility from international patient billing
- Re-rating driven by accreditation recognition and premium care credentials
- Broader service base including diagnostics, wellness, and mother-child care verticals
Artemis Medicare Services Share Price Target & Forecast (2025-2050)
This long-term stock price forecast for Artemis Medicare Services Ltd. is based on historical market trends, the company’s growth prospects, and industry analysis. While forecasting stock prices for the long term involves uncertainty, these forecasts help investors gain insight into potential future price movements.
📊 The following table presents the Artemis Medicare Services share price target & forecast from 2025 to 2050, based on current market trends and available data.
| Year | Min. Price | Max. Price |
|---|---|---|
| 2025 | ₹ 214.81 | ₹ 253.51 |
| 2026 | ₹ 242.51 | ₹ 312.48 |
| 2027 | ₹ 302.50 | ₹ 371.71 |
| 2028 | ₹ 361.08 | ₹ 431.07 |
| 2029 | ₹ 419.76 | ₹ 490.11 |
| 2030 | ₹ 478.53 | ₹ 542.38 |
| 2031 | ₹ 516.22 | ₹ 644.68 |
| 2032 | ₹ 570.42 | ₹ 710.40 |
| 2033 | ₹ 624.47 | ₹ 775.94 |
| 2034 | ₹ 678.52 | ₹ 841.48 |
| 2035 | ₹ 732.57 | ₹ 907.03 |
| 2040 | ₹ 1,058.86 | ₹ 1,178.96 |
| 2050 | ₹ 1,629.73 | ₹ 1,804.94 |
The Artemis Medicare Services Ltd. share price targets provided here are for informational purposes only. Both short-term and long-term stock price predictions are based on historical data and market trends, but actual prices may vary due to market fluctuations and external factors. This forecast assumes positive market conditions and does not account for unforeseen risks, economic uncertainties, or company-specific challenges. Investors should conduct their research before making any financial decisions.
Live Stock Chart & Price Trends – Artemis Medicare Services Ltd.
Track Artemis Medicare Services Ltd.’s stock performance in real time with our interactive chart below. This live tool provides up-to-the-minute price movements, trading volume, and market trends, helping investors and market watchers stay fully informed. Easily switch between intraday, daily, weekly, or monthly views, and apply a variety of technical indicators to support deeper analysis. Whether you’re actively trading or simply monitoring the market, this chart offers the insights you need to make smart, timely decisions.
🔗 Also Read: Divi’s Laboratories Share Price Target: Future Outlook
Divi’s Laboratories Ltd. is a globally recognized Indian pharmaceutical company known for manufacturing active pharmaceutical ingredients (APIs), intermediates, and custom synthesis of drug compounds. Read more
Expert Opinions & Market Sentiment
Brokerage & Analyst Ratings
- Axis Securities: “Accumulate – Artemis’s blend of tertiary expertise and neighbourhood care models supports long-term strategic growth.”
- HDFC Securities: “Positive – A winning combination of technology-led care and accessible formats positions Artemis for evolving healthcare needs.”
- Motilal Oswal: “Buy – Delivery of complex clinical services and the launch of Lite centres will enhance scale and market reach.”
Investor Sentiment & Market Trends
- Institutional Investors: Growing interest due to Artemis’s well-defined expansion plan and clear clinical positioning.
- Retail Participation: Retail investors are increasingly attracted to Artemis’s brand strength and healthcare-focused investment thesis.
- Market Mood: Generally optimistic—driven by execution on capacity, expanding patient volumes, and strategic accreditation credentials.
❓FAQs
What services does Artemis provide?
Artemis offers multi-specialty tertiary care, mother-child wellness, compact outpatient clinics, diagnostics, and wellness programs.
Is Artemis accredited globally?
Yes — Artemis holds NABH, NABL, and multiple JCI accreditations, reflecting its alignment with international clinical standards.
Are expansions underway?
Yes — the latest expansion includes Tower III in the flagship location, and multiple Artemis Lite neighbourhood clinics are already operational or under development.
Does it serve international patients?
Approximately one-quarter of its patients are from overseas, indicating traction in medical tourism and higher-margin international billing.
Price Prediction Methodology
Our predictions combine expert analysis, technical indicators, and algorithmic models to provide an informed outlook.
📊 Want to know more? Click here to read our full methodology.
